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Structure of the polyisoprenyl-phosphate
glycosyltransferase GtrB and insights
into the mechanism of catalysis
Chiara Ardiccioni1,*, Oliver B. Clarke2,*, David Tomasek1, Habon A. Issa3,4, Desiree C. von Alpen3,4,
Heather L. Pond3,4, Surajit Banerjee5, Kanagalaghatta R. Rajashankar5, Qun Liu6, Ziqiang Guan7, Chijun Li7,
Brian Kloss8, Renato Bruni8, Edda Kloppmann9,10, Burkhard Rost9,10, M. Chiara Manzini3,4, Lawrence Shapiro2
& Filippo Mancia1
The attachment of a sugar to a hydrophobic polyisoprenyl carrier is the first step for
all extracellular glycosylation processes. The enzymes that perform these reactions,
polyisoprenyl-glycosyltransferases (PI-GTs) include dolichol phosphate mannose synthase
(DPMS), which generates the mannose donor for glycosylation in the endoplasmic reticulum.
Here we report the 3.0Å resolution crystal structure of GtrB, a glucose-specific PI-GT from
Synechocystis, showing a tetramer in which each protomer contributes two helices to a
membrane-spanning bundle. The active site is 15Å from the membrane, raising the question
of how water-soluble and membrane-embedded substrates are brought into apposition
for catalysis. A conserved juxtamembrane domain harbours disease mutations, which
compromised activity in GtrB in vitro and in human DPM1 tested in zebrafish. We hypothesize
a role of this domain in shielding the polyisoprenyl-phosphate for transport to the active site.
Our results reveal the basis of PI-GT function, and provide a potential molecular explanation
for DPM1-related disease.
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I
n humans and bacteria alike, the first step in all glycosylation
reactions that take place in outer cellular compartments
involves the attachment of a sugar in the cytoplasm to a
hydrophobic carrier molecule to generate a sugar donor molecule
for transmembrane (TM) export1. In eukaryotes, such donors are
necessary for processes including N- and O-linked protein
glycosylation and glycophosphatidylinositol anchoring. In
Gram-negative bacteria, they contribute to the biosynthesis of
the cell wall, and its modifications that underlie serotype
conversion, a bacterial mechanism for evasion of the host
immune response2. Sugar attachment to hydrophobic carrier
molecules for transport across membranes is catalysed by
polyisoprenyl-glycosyltransferases (PI-GTs), integral membrane
enzymes conserved across all kingdoms of life3. Bacterial PI-GTs
utilize undecaprenyl-phosphate (UndP) as the sugar carrier,
whereas their eukaryotic and archaeal counterparts use the related
dolichol phosphate (DolP)3. Mutations in the human PI-GT
dolichol phosphate mannose synthase (DPMS) catalytic subunit
DPM1 (refs 4,5)—the enzyme that charges DolP with mannose
for protein glycosylation—cause congenital disorders of
glycosylation1,6–8 type 1e resulting in severe phenotypes
including developmental delay and vascular abnormalities9.
PI-GTs have a predicted two-domain architecture composed of
a cytosolic amino-terminal catalytic domain and a TM region, but
their functional assemblies, detailed structures and catalytic
mechanisms remain unknown.
Here we report the first structure and functional characteriza-
tion of a representative PI-GT, GtrB from Synechocystis sp.
PCC6803 (ref. 10; GtrBSyn) to 3.0 Å resolution. We describe
enzyme assays that show that recombinant GtrBSyn expressed in
Escherichia coli attaches a glucose molecule to UndP, a key
reaction for immune evasion by aggressive pathogens such as
Shigella flexneri and Salmonella enterica11,12. GtrB is a tetramer in
which each protomer contributes two TM helices to a membrane-
spanning bundle. The soluble glycosyltransferase (GT) domains
are separated from the TM helices by a juxtamembrane region
that positions the active site 15Å below the membrane surface.
This structure, together with results of functional mutagenesis on
GtrBSyn and human DPM1 in a zebrafish model, provides the
framework to understand how PI-GTs work in both prokaryotes
and eukaryotes.
Results
Crystallization and structure determination. To determine the
structure of a representative member of the PI-GT family,
we followed a structural genomics approach, and screened 45
prokaryotic PI-GTs, identified via a bioinformatics analysis, for
expression in E. coli and stability in detergents amenable to
crystallization13. GtrBSyn, the PI-GT from Synechocystis sp.
PCC6803, was the most promising. Indeed, we produced
crystals of this protein, in the detergent n-decyl-b-D-
maltopyranoside (DM), which diffracted X-rays anisotropically
to 3.2/3.6 Å resolution. We determined this structure by multi-
crystal single-wavelength anomalous diffraction (SAD)14 analysis
of the selenomethionine-substituted protein. Subsequently,
although probing the function of the enzyme with structure-
based mutagenesis, we produced crystals of the point mutant
F215A, which fortuitously diffracted isotropically to 3.0 Å,
allowing us to improve the quality of the model (Table 1).
F215A, which resides in a functionally relevant region of the
protein, has compromised catalytic activity (Supplementary
Table 1), but the structures are essentially identical, and unless
indicated otherwise, we show here the better F215A model.
Functional characterization of GtrB from Synechocystis. GtrB
was initially identified in bacteriophage-infected Shigella flexneri
strains in a cluster of genes that mediate serotype conversion by
glucosylating- and acetylating-specific residues in the O-antigen
of the cell wall11,15. GtrB is a bona fide PI-GT as it carries out the
Table 1 | Data collection and refinement statistics.
SeMet-GtrB* GtrB GtrB (F215A) GtrB (WO4)
Wavelength (Å) 0.979 0.979 0.979 1.02
Resolution range (Å) 46.79–3.21 (3.40–3.10) 19.99–3.194 (3.308–3.194) 40.79–3.0 (3.107–3.0) 37.82–4.498 (4.658–4.498)
Space group C 2 C 2 C 2 C 2
Unit cell
a 155.866 157.331 154.159 155.858
b 138.771 137.518 142.263 141.618
c 101.048 101.448 102.024 101.463
b 98.249 98.5 97.158 97.99
Total reflections 863,961 (105,225) 260,786 (24,889) 182,341 (17,880) 98,386 (9,396)
Unique reflections 38,430 (4,716) 35,029 (3,408) 43,375 (4,247) 13,024 (1,282)
Multiplicity 22.5 (22.3) 7.4 (7.3) 4.2 (4.2) 7.6 (7.3)
Completeness (%) 98.8 (99.3) 98.0 (97.0) 98.0 (98.0) 99.0 (99.0)
Mean I/sigma(I) 21.5 (1.2) 12.84 (1.32) 17.65 (0.99) 7.81 (2.32)
Wilson B-factor 105.4 125.7 112.6 195.8
Rmerge 0.123 (3.55) 0.089 (1.32) 0.045 (1.30) 0.180 (1.71)
CC1/2 0.997 (0.519) 0.999 (0.684) 0.997 (0.692) 0.998 (0.763)
Rwork — 0.220 (0.321) 0.249 (0.389) —
Rfree — 0.279 (0.374) 0.276 (0.415) —
Number of non-hydrogen atoms — 9,254 9,243 —
Macromolecules — 9,150 9,139 —
Ligands — 104 104 —
RMS (bonds) — 0.009 0.004 —
RMS (angles) — 1.19 0.54 —
Ramachandran favoured (%) — 90 94 —
Ramachandran outliers (%) — 0.86 0.52 —
Clashscore — 14.95 5.77 —
Statistics for the highest resolution shell are shown in parentheses.
*Friedel pairs (Iþ/I ) treated as separate reflections; RMS, Root mean square.
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first step in the glucosylation process, generating UndP-glucose
on the cytoplasmic face of the inner membrane (Fig. 1a), which is
later utilized as a glucose donor during glucosylation of the
O-antigen. To assess the PI-GT function of the enzyme from
Synechocystis, we performed mass spectrometry on lipid extracts
from E. coli cells overexpressing GtrBSyn, revealing specific
accumulation of UndP-glucose (Fig. 1b). In vitro assays on
GtrBSyn, monitoring the UndP-specific accumulation of 14C in a
water-insoluble phase from UDP-14C-glucose also confirmed
the synthesis of UndP-glucose from UDP-glucose and UndP
(Fig. 1c).
The structural architecture of GtrB. The structure shows that
GtrBSyn is a tetramer (Fig. 2a,b), with each protomer consisting
of an N-terminal cytosolic GT domain of the GT-A fold16,
a juxtamembrane region, two TM helices (TM1 and TM2), which
form a compact stalk anchoring the intracellular domains to the
membrane, and a short C-terminal beta-hairpin (Fig. 2c–f and
Supplementary Fig. 1). The short beta-hairpin at the C-terminus
bridges the interaction between adjacent subunits in the tetramer
(Supplementary Fig. 2). Two amphipathic juxtamembrane helices
(JM1 and JM2; Fig. 2c–f and Supplementary Fig. 1) lie at the
cytoplasmic surface of the membrane, oriented parallel to one
another, and sharing a hydrophobic interface (Supplementary
Fig. 3). JM1 is located in an internal loop in the GT domain,
whereas JM2 is an N-terminal extension of TM1 (Supplementary
Fig. 1) analogous to the ‘slide helix’ found in potassium channel
structures17. JM1 was first identified by analysis of the predicted
secondary structure18, which suggested the presence of a
conserved amphipathic helix located in the b5-6 loop and
spanning residues 130–146. Although the density in this region is
poorer than in other regions of the map (Supplementary Figs 4
and 5a), the presence of two methionine residues helped confirm
the register of the sequence using selenomethionine-labelled
protein crystals (Supplementary Fig. 5b).
Despite unambiguous experimental density for the majority
of the molecule, electron density for the periplasmic loop
that connects the TM helices is poor, leading to two possible
topologies for subunit association in the tetramer (Supplementary
Fig. 6). Based on our interpretation of the maps, we believe the
most probable topology results in the C-terminal short beta-
hairpin forming close interactions with the originating protomer
(Supplementary Fig. 6a), rather than with the adjacent one
(Supplementary Fig. 6b). The coordinates we have deposited
leaves this ambiguity unresolved, with the protomer divided into
two chains. However, for the sake of clarity, all figures showing
the GtrBSyn structure depict the topology we judge to be most
probable.
Donor and acceptor sites in GtrB. GtrBSyn crystals were typically
soaked in UDP-glucose before cryoprotection and freezing, as this
step led to better resolution and reproducibility in the quality of
the diffraction pattern. This soaking step had the additional
advantage of allowing us to specifically identify the mono-
saccharide donor site. The UDP-glucose donor substrate binds in
a shallow cleft on the surface of the cytosolic GT domain, in a
similar position to that determined in other structures of GT-A
fold GTs19 (Fig. 3a). A divalent cation mediates the interaction
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Figure 1 | GtrB catalyses the formation of UndP-glucose in vivo and in vitro. (a) GtrB (TM domain in blue, GT domain in orange) catalyses the
transfer of a glucose from UDP-glucose to UndP, producing UndP-glucose. (b) Cells overexpressing GtrB accumulate a species detected by negative ion
ESI/MS at m/z of 1,007.75, corresponding to the [M-H]-ion of UndP-glucose. Its identity was further confirmed by tandem mass spectrometry (MS/MS).
(c) When incubated with varying concentrations of UndP for 1 h, membranes prepared from GtrB-overexpressing cells accumulate UndP-glucose
(UndP-Glc) in a concentration-dependent manner (circles), whereas those prepared from control cells overexpressing a membrane protein of unrelated
function do not (squares). Error bars are provided as ±s.e.m., n¼ 3.
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between the diphosphate of the UDP and a signature DXD
motif20 (94Dx96D in GtrBSyn). The anomalous signal of
manganese soaked into the crystals was used to positively
identify the ion-binding site although magnesium appears to be
preferred for optimal activity of the enzyme (Supplementary
Fig. 7a). Despite the fact that UDP-glucose was soaked into the
crystals immediately before cryoprotection and freezing,
interpretable density was only observed for the UDP
(Supplementary Fig. 7b), indicating that the glucose is either
poorly ordered or was hydrolysed before data collection, as has
previously been observed for other GTs21.
To identify the UndP acceptor site, we performed anomalous
diffraction experiments with a GtrBSyn crystal soaked with
tungstate, a phosphate analogue with a larger X-ray anomalous
scattering signal (Fig. 3a and Supplementary Fig. 8). Remarkably,
the anomalous difference density overlays perfectly with
the position expected from structural alignments with other
GT-acceptor complexes from soluble enzymes of the GT-A fold
(Supplementary Fig. 9a).
In the 3.0 Å resolution structure without tungstate, we cannot
see side chain density for R122, and the segment between R197
and N208, and the limited resolution (4.5 Å) of the data with
tungstate does not allow us to reliably assign previously
disordered sequence in the map.
However, we can hypothesize that R122 and R200, which are
universally conserved among prokaryotic and eukaryotic GTs
that process lipid-phosphate acceptors (Supplementary Fig. 9b),
will coordinate the acceptor. Mutation of either of these two
arginines to glutamine or alanine severely compromised GtrBSyn
activity, suggesting that they play an important role in binding
the phosphate of the acceptor (Fig. 3b).
The chemistry of catalysis. The transfer of a sugar group to the
acceptor molecule can occur with either inversion or retention of
the stereochemistry at the anomeric carbon. The corresponding
two classes of GTs are known as inverting and retaining,
respectively22. Overall, the data suggest that GtrB is an inverting
GT, based both on previous sequence-based classification and
the shallow, solvent-exposed nature of the active site seen in the
GtrBSyn structure, a feature typical of inverting GTs23. The
mechanism of catalysis, while broadly similar to that described
for other inverting GTs, differs in detail due to the nature of the
acceptor24. Unlike most GTs, which attach a saccharide donor at
a neutral, protonated hydroxyl on the acceptor substrate, GtrB
catalyses the attachment of glucose to the phosphate oxygen,
which is expected to be deprotonated under physiological
conditions. A key step in the reaction mechanism of
conventional inverting GTs involves the participation of a
catalytic base residue, which abstracts a proton from the
acceptor, enabling nucleophilic attack by the resultant lone pair
of electrons at the anomeric carbon24,25. When the acceptor is
already deprotonated, it is unclear whether this step is necessary,
and it seems likely that the role of a catalytic acid residue in
assisting hydrolysis of the UDP-sugar donor will be more
prominent. Based on structural alignment with other GT-A fold
GTs and mutagenesis data showing that GtrBSyn activity is
abolished in the D157N mutant (Fig. 3b), we identified D157 as a
putative catalytic acid, and propose a tentative scheme for how
the reaction catalysed by GtrB may take place, and describe it
here in the context of the GtrBSyn structure (Fig. 3c).
Bringing substrates into apposition for catalysis to occur. The
active site of GtrBSyn is located in the cytosol B15Å from the
TMJM
GT C
N
C
N
90°
90°
Figure 2 | Architecture of GtrB, an integral membrane PI-GT. The tetrameric assembly of GtrB, in which each of the four polypeptide chains is
represented as a ribbon drawn in a different colour, is shown here (a) from a position orthogonal to the TM helices and (b) looking down the fourfold
symmetry axis of the tetramer from the extracellular side. (c) A single protomer is shown. The protomer is comprised of a GT-A fold GTdomain (orange),
two amphipathic juxtamembrane helices (grey; juxtamembrane (JM)), two TM helices (blue) and a C-terminal b-hairpin (red). (d,e) The GtrB tetramer is
shown in the same two views and orientations as in a,b, with three subunits represented in grey ribbons and the fourth in rainbow colouring from the
N-terminus (blue) to the C-terminus (red). (f) The GtrB monomer shown in the same orientation as in c, represented in rainbow colouring from the
N-terminus (N; blue) to the C-terminus (C; red).
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membrane (Supplementary Fig. 11). This raises the question
of how the hydrophobic acceptor from the membrane and
hydrophilic donor from the cytosol are brought into proximity
for catalysis to occur; that is, whether the GT domain moves to
the membrane, or whether the lipid-phosphate acceptor is
translocated to the active site. We favour the latter mechanism for
three reasons. First, B900Å2 of predominantly hydrophobic
surface is buried between each pair of GT domains in the cytosol,
with eight inter-subunit hydrogen bonds and two salt bridges
formed at each interface (Supplementary Fig. 2), suggesting a
stable structure that is unlikely to disassemble for the GT domain
to move to the membrane. Second, the enzyme is highly specific
for acceptors built from isoprenyl units (Supplementary Fig. 10),
but the lack of strong conservation in the TM region
(Supplementary Fig. 11) suggests that specificity for the lipid may
reside elsewhere in the protein. Third, we have identified several
absolutely conserved hydrophobic and basic residues in the jux-
tamembrane region (Supplementary Figs 11 and 12a) that could
in principle form a solvent-shielded pathway for translocation of
substrate from the membrane to the active site where the acceptor
phosphate is bound by the side chains of R122 and R200 (Fig. 4a–
c). Functional requirements for these residues (Fig. 4d), and their
conserved pattern (Supplementary Figs 11 and 12a), lead us to
put forth the hypothesis that as the UndP diffuses along this
pathway, with its isoprenyl groups shielded by the hydrophobic
residues, the phosphate headgroup could form transient ionic
interactions with the positively charged moieties of the basic
residues (Fig. 4a–c). To investigate this hypothesis, we first pro-
duced GtrBSyn with mutations at each of the conserved residues
R122, R125, K132, A136, Y140, R200, L212, A216 and R290, in
the juxtamembrane region. Mutations at any of these sites led a
complete loss of enzymatic activity (Fig. 4d). However, the
mutant proteins could be expressed, solubilized and purified in a
non-ionic detergent at levels comparable to wild type, with a
similar elution profile in size-exclusion chromatography, sug-
gesting that the overall structure was unaffected (Supplementary
Fig. 13). As further proof that the fold of GtrBSyn was unaffected
by mutagenesis, we crystallized and determined the structure of
several of these point mutants (Y209A, L212F, A216M, A136M,
R122Q, T135A, R145A). Finally, functional assays on single-point
mutations of each of the residues of JM1 and JM2 to alanine show
that the entire region is extremely sensitive to even minor
perturbations in structure (Supplementary Fig. 14), highlighting
the importance of the juxtamembrane region in GtrB function.
GtrB as a structural model to study DPMS function. Although
PI-GTs have high sequence variability, and they may consist of
one or multiple chains, the overall architecture comprising a
soluble GT domain, a juxtamembrane region composed of two
amphipathic helices and one or more TM segments is conserved.
The TM region of the human DPMS complex is composed of two
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separate polypeptide chains, but there is high conservation in the
key functional residues in the juxtamembrane region we have
identified here (Supplementary Fig. 12a). Interestingly, disease-
causing mutations G152V and S248P in human DPM1, the
catalytic subunit of the DPMS complex, have been mapped to the
JM1-GT and JM2-GT linkers, and are conserved in GtrB (Fig. 4e
and Supplementary Fig. 12b)26,27. Another disease mutant, R92S,
which causes the most severe phenotype, is expected to be located
close to the active site. Together, these observations lead us to
suggest that DPMS and other PI-GTs are likely to function by
similar mechanisms. To investigate this hypothesis, we performed
assays to determine whether GtrB and DPMS shared functional
similarities. First, we asked whether GtrB could attach its donor
substrate to DolP, the acceptor used by DPMS and all other
eukaryotic PI-GTs. Indeed, GtrBSyn could readily glucosylate
DolP (Supplementary Fig. 12c). Second, we generated a zebrafish
model of dpm1 loss of function by knocking-down dpm1 in
zebrafish fertilized oocytes using two independent morpholino
antisense oligonucleotides (MOs) targeting either translation
(start site) or transcription (donor splice site in exon 1) at 4 and
8 ng, respectively. MO concentrations were carefully titrated to
avoid nonspecific binding effects observed with high MO
concentration, and knockdown was measured by quantitative
PCR (Supplementary Fig. 15a,b). A scrambled control MO was
used at equal concentrations to show that the effects were specific
to dpm1 (Supplementary Fig. 15c). Identical phenotypes were
observed for both MOs and dpm1 morphants recapitulated most
features of congenital disorder of glycosylation type 1e (CDG1e)
associated with DPM1 mutations, including developmental delay,
microcephaly, ocular defects and vascular anomalies, which were
fully evident at 2–3 days post fertilization (d.p.f.; Fig. 4f and
Supplementary Fig. 15d,e)9. Injection of human DPM1 mRNA
was able to significantly rescue the dpm1 morphant phenotypes
showing that the function is conserved between humans and
zebrafish, and that the phenotypes observed are due to the loss of
dpm1 (Supplementary Fig. 15f). Injection of DPM1 mRNA alone
had no effect on development (Supplementary Fig. 15g). To test
whether the proposed mechanisms of action is plausible in
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human DPM1, we co-injected MO with mRNA carrying
mutations in R147 and R234, which correspond to R122 and
R200 in GtrBSyn. The mutant mRNAs failed to rescue dpm1
knockdown, suggesting that these residues are critical for function
(Fig. 4g). Finally, we tested all known human mutations, R92S,
G152V and S248P, which lead to variable phenotypic
presentations. As observed for wild-type DPM1, overexpression
of mutated mRNA alone had no effect indicating that these
missense changes do not generate a gain of function
(Supplementary Fig. 15g). R92S and G152V, which cause severe
CDG1e, showed severe loss of function, as was previously shown
in enzymatic assays9,26, whereas S248P, which causes a milder
version of the disease27, only partially affected DPM1 function
(Fig. 4g). Interestingly, a similar trend in activity levels was
observed in GtrBSyn for the G127V (inactive) and T205P
(partially inactive) mutants (Supplementary Fig. 12d).
Discussion
The structure of GtrB from Synechocystis sp. determined here at
3.0 Å resolution, is the first for a representative PI-GT, enzymes
that attach a sugar to a lipid carrier for use in glycosylation
reactions3. GtrBs, including GtrBSyn, attach a glucose molecule to
UndP11,12, the conserved sugar-carrier lipid in prokaryotes
(Fig. 1). The structure shows that GtrB is a tetramer in which
each protomer has two membrane-spanning helices with a
catalytic domain similar to those of soluble GTs attached through
a juxtamembrane region (Fig. 2). Although the catalytic GT
domain and the JM region are conserved across the family, it
remains unclear whether other PI-GTs will have similar TM
topologies.
Similarities in the catalytic domain with other GT-A fold GTs,
coupled to functional mutagenesis data on GtrBSyn, have allowed
us to identify a conserved aspartic acid (D157) as putative
catalytic acid (Fig. 3b), and propose a scheme for how the
reaction catalysed by GtrB may take place (Fig. 3c).
In the GtrBSyn structure, the GT domains of the tetramer are
B15Å distant from the membrane surface (Supplementary
Fig. 11), and separated from it by the juxtamembrane region. This
arrangement raises the question of how hydrophobic substrates
originating from the membrane and hydrophilic substrates from
the cytosol are brought into apposition for catalysis. Overall our
results, including the apparent rigidity of the assembly between
the four catalytic domains of the tetramer (Supplementary Fig. 2)
and functional loss by mutations in the juxtamembrane region
(Fig. 4d and Supplementary Fig. 14), favour a mechanism where
hydrophobic polyisoprenyl-phosphates translocate from the
membrane to the cytosolic-active site (Fig. 4a–c), although
further studies will be required to understand the molecular
details of this mechanism.
The sequence conservation we observe suggests that all PI-GTs
are likely to function similarly. The GtrB structure, together with
results of functional mutagenesis on this enzyme and on the
human DPM1 in a zebrafish model, also presented here (Fig. 4e–g
and Supplementary Fig. 14), provide a framework for under-
standing PI-GT structure and function in both prokaryotes and
eukaryotes.
Methods
Target identification and mutagenesis. GtrB from the cyanobacterium
Synechocystis sp. PCC 6803 (UniProt, accession # Q55487) was initially identified
as a promising candidate for crystallization experiments by the NYCOMPS
(New York Consortium on Membrane Protein Structure) high-throughput target
identification and screening pipeline28,29. The open reading frame encoding GtrB
was amplified by PCR using Synechocystis sp. PCC 6803 genomic DNA as template.
Primers used for amplification were 50-tacttccaatccaatgccACCATTGAACTGTCTA
TTGTGATT-30 (forward) and 50-ttatccacttccaatgCTAATTAAGTTTTTCCAATG
GCAAA-30 (reverse), where upper case letters indicate gene-specific sequences and
lower case letters indicate vector-specific sequences. The amplified product was
cloned into the expression vector pMCSG7 by ligation-independent cloning,
introducing a hexahistidine tag and a tobacco etch virus (TEV) protease cleavage
site at the N-terminus of the polypeptide30. The identity of the resulting construct
was verified by DNA sequencing. Sequence alignments were performed using
PRALINE and PROMALS-3D (refs 31,32). All point mutants were prepared using
the QuikChange site-directed mutagenesis kit (Agilent).
Protein expression and purification. To produce both native and the
selenomethionine-substituted protein, GtrBSyn was overexpressed in E. coli strain
BL21 (DE3) pLysS. Cells were grown in 2xYT medium containing 100 mgml 1
ampicillin and 50 mgml 1 chloramphenicol at 37 C. At an OD600 value of 0.8,
temperature was reduced to 22 C and protein expression induced 15min later
with the addition of 0.2mM isopropyl b-D-thiogalactopyranoside. When producing
the selenomethionine-substituted protein, the protocol was the same aside from the
following. Cells were grown in minimal media containing M9 salts (M9 SeMET
High-Yield Growth Media Kit, Shanghai Medicilon Inc.) with a supplemental
150mg of selenomethionine per litre of culture, and protein expression was
induced with 0.4mM isopropyl b-D-thiogalactopyranoside. The purification
protocol, as described below, is the same for both native and the selenomethionine-
substituted protein. Cells were harvested after overnight induction, then
re-suspended in lysis buffer (20mM Na-HEPES, pH 7.5, 150mM NaCl,
20mM MgSO4, 10 mgml 1 DNase I, 10 mgml 1 RNase A, 1mM
tris(2-carboxyethyl)phosphine (TCEP), 1mM phenylmethanesulfonylfluoride and
Complete Mini EDTA-free protease inhibitor cocktail (Roche) as described in the
instructions. Cells were lysed using an Avestin Emulsiflex C3 homogenizer, and
then solubilized for 1 h by addition of (Anagrade, Affymetrix) to 1% (w/v) in a
typical volume of 50ml for a pellet from an 800ml growth culture. After pelleting
insoluble debris by ultracentrifugation (134,000g, 30min) and filtering the
supernatant (0.22 mm), solubilized GtrBSyn was purified by metal-affinity followed
by size-exclusion chromatography (SEC) using a 24-ml Superose 12 column
(GE Healthcare). The SEC buffer contained 20mM HEPES, pH 7.0, 150mM NaCl,
1mM TCEP and 0.2% (w/v) DM. Before crystallization, the peak fractions from
SEC were concentrated typically to 15mgml 1 (estimated from A280 nm) using a
centrifugal concentrator (Millipore) with a molecular weight cutoff of 50 kDa.
Approximately 2mg of purified GtrBSyn could be obtained starting from an 800-ml
bacterial culture. Small-scale expression tests were performed by essentially the
same protocol as for the larger-scale purification, starting from 80mg of a cell pellet
taken from a larger-scale protocol. For small-scale expression tests, cells were lysed
by sonication.
Crystallization. Initial crystals were obtained by sitting drop vapour diffusion at
22 C. The optimized crystallization protocol involved dispensing 600 nl of the
purified protein solution (15mgml 1) and 300 nl of reservoir solution (containing
16-18% PEG600 (v/v), 0.12M Tris/HCl, pH 9.0, 0.1M NaCl and 1mM TCEP)
under 1 ml of silicone oil, in 96-well Axygen sitting-drop plates. Crystals typically
appeared after 1–2 days and grew to a final size of B150 mm in each dimension.
Before cryoprotection, a reservoir solution containing 5mM MnCl2 and 25mM
UDP-glucose was added to the crystal-containing drop for 1 h. The crystals used
for the tungstate anomalous difference Fourier map were soaked overnight in
reservoir solution containing 10mM sodium tungstate before cryoprotection.
Crystals were flash-frozen by immersion in liquid nitrogen after incubating briefly
in reservoir solution containing 28% (v/v) PEG600. Crystals of the native and the
selenomethionine-substituted protein typically diffracted anisotropically to
3.2–3.8 Å resolution. GtrBSyn crystallizes in space group C2, with unit cell
parameters (Å) a¼ 157.3, b¼ 137.5, c¼ 101.4, b¼ 98.5. One tetramer is in the
asymmetric unit. Crystals of the F215A mutant were produced in the same way and
diffracted isotropically to 3.0 Å resolution.
Diffraction data collection and processing. Diffraction data were collected on
beamline X4C at the NSLS, Brookhaven National Laboratory, and on beamline
24-ID-C at the Advanced Photon Source. Data sets collected above the Se K-edge
from four selenomethionine-substituted crystals were merged and used for
structure solution at 3.2 Å by multi-crystal SAD14. The data were indexed,
integrated, scaled and merged using XDS and XSCALE33. Selenium sites were
located using SHELXD, and refined in SHARP34. Density modification, including
solvent flattening, histogram matching and four-fold non-crystallographic
symmetry averaging, was performed using DM to give an initial experimentally
phased electron density map35.
Model building and refinement. An initial model was built using the auto-tracing
option of SHELXE, and improved using BUCCANEER36–38. This model was
manually completed using COOT and refined using the PHENIX crystallographic
software package, alternating between cycles of manual building in COOT and
refinement in PHENIX39,40. Translation/Libration/Screw (TLS) parameterization
was employed in the latter stages of refinement (using phenix.find_tls_groups to
generate Translation/Libration/Screw (TLS) group boundaries), and riding
hydrogens were included in the last cycle of refinement. Torsion-angle non-
crystallographic symmetry restraints were used throughout refinement. The final
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models have an R/Rfree of 0.2281/0.2595 (WT) and 0.2685/0.3044 (F215A). A
snapshot of typical electron density in the final 2mFo-DFc map is included as well
as the anomalous difference map derived from selenomethionine-labelled wild-type
crystals used for phasing and sequence registration (Supplementary Fig. 5). The
quality of the final models was analysed using the validation module of the
PHENIX package, which incorporates Molprobity clash score, density correlation
and rotamer analysis41. For F215A, 93% of residues are in the favoured region of
the Ramachandran plot, with 0.3% outliers. Full data collection and refinement
statistics are given in Supplementary Table 1. Protein structure figures were
prepared using UCSF Chimera42. Calculations of the surface area buried at the
subunit interfaces were performed using the PISA interface in COOT43.
Mass-spectrometry analysis of lipids. The procedures for lipid extraction
and liquid chromatography-mass spectrometry analysis were previously
described44. Briefly, lipids were extracted from whole-cell samples (of either
GtrBSyn-overexpressing cells or a negative control expressing an unrelated
membrane protein) using a neutral Bligh-Dyer method45. After extraction, the
dried lipids were dissolved in chloroform/methanol (2:1(v/v)). The extracted lipid
species were separated by normal phase liquid chromatography (LC) using an
Ascentis Silica HPLC column. LC eluents were injected into the ion spray source of
a TripleTOF 5,600 quadrupole time-of-flight tandem mass spectrometer (AB
SCIEX. The mass spectrometry/mass spectrometry analysis used nitrogen as the
collision gas. Data analysis was performed using the Analyst TF 1.5 software.
In vitro functional assay of GtrB activity. An assay for the activity of wild-type
and mutant GtrBSyn constructs using UDP-14C-glucose as a radiolabelled tracer
was adapted from a previously published protocol11. Briefly, crude membranes
were isolated from cell lysate by centrifugation at 134,000g for 1 h and dispersed in
resuspension buffer (100mM Tris/acetate pH 8.5) before storage at  80 C for
later use. On the day of the assay, the membranes were thawed, resuspended by
sonication and washed two times with resuspension buffer. One milligram of crude
membranes was used for each reaction, in a final volume of 250ml. 1mM EDTA,
10mM MgCl2 and a variable (0–200 mM final concentration) amount of UndP
(Indofine Chemicals) were added to the resuspended membranes, followed by a
sonication step to facilitate incorporation of the UndP into the membrane. The
radiolabelled substrate (0.25 mM UDP-14C-glucose) was then added and the
mixture incubated at room temperature for 1 h. After extracting twice with butanol
followed by two washes with water, 180 ml of the organic phase was combined with
10 volumes of scintillation fluid and radioactivity measured using a scintillation
counter (Perkin Elmer). Assays testing acceptor lipids other than UndP were
performed in the same way, with 100 mM of the alternate lipid in place of UndP.
DolP, decaprenyl phosphate, octaprenyl phosphate and hexaprenyl phosphate were
obtained from Indofine Chemicals, and dodecyl phosphate and phosphatidic acid
were obtained from Sigma-Aldrich.
Alternatively, functional assays were also performed using purified protein
reconstituted into liposomes. Liposomes and proteoliposomes were prepared as
described46. Briefly, E. coli polar lipid extract (Avanti) and phosphatdiylcholine
(PC, Avanti) were mixed in a 3:1 ratio (w/w) by dissolving in chloroform, and
chloroform was removed under a stream of nitrogen gas. Lipids were resuspended
in 100mM HEPES, pH 7.5, buffer containing 1.5% (w/v) 1-O-n-Octyl-b-D-
glucopyranoside (OG, Anagrade, Affymetrix) and the detergent was removed by
dialysis. The resulting liposomes were divided into aliquotes, frozen in liquid
nitrogen and stored at  80 C. For proteoliposome formation, the concentration
of thawed liposomes was adjusted to 10mgml 1 and 0.11% (w/v) Triton X-100
was added to the liposome-containing solution and purified protein was then
added in a ratio of 1:80 (0.125mg protein to 10mg lipid), and after a 15-min
incubation, detergent was removed by the addition of Bio-Beads SM-2 (Bio-Rad).
Proteoliposomes were separated and removed from the Bio-Beads by careful
pipetting, their concentration adjusted by ultracentrifugation and resuspension in
the correct volume of buffer. Proteoliposomes were divided into aliquots, flash
frozen in liquid nitrogen and stored at  80 C. 5 mg of proteoliposomes at
10mgml 1 were used per assay, in a final volume of 250ml. All subsequent steps
were performed as described above for functional assays performed on membranes.
Assays using protoliposomes were used to test activity of G127V and T205P
GtrBSyn mutants.
Protein expression levels were normalized by quantifying the intensity of bands
on an SDS–PAGE gel, after solubilization and purification by metal-affinity
chromatography in DM, using ImageJ47. The expression levels of mutants were
compared with wild-type protein, and activity levels were then adjusted based on
this normalization.
Functional assay of human DPM1 activity in zebrafish. Fertilized zebrafish
(Danio rerio) oocytes were obtained from Oregon AB breeders maintained in the
Animal Research Facility at the George Washington University as described
earlier48. All animal work was performed in compliance with protocols approved
by the George Washington University Animal Care and Use Committees.
Microinjection was performed on a PLI-100A Pico-Injector (Harvard Apparatus)
at the one or two cell stage (20–45min post fertilization) using pulled borosilicate
pipettes. MO sequences were designed by Gene Tools LLC to target the start site or
intron 1 splice donor site of dpm1 (ENSDART00000079591) as follows: dpm1 start
50-TACTTCTGCGGCTCGCCATGTTGGC-30 and dpm1 splice 50-TTCAGGTTT
CGCAATTACCTTTCGC-30 . Standard control MOs were provided by Gene Tools.
MOs were injected at 1–4 ng for dpm1 start or 8–20 ng for dpm1 splice in 1
Danieau solution (58mM NaCl, 0.7mM KCl, 0.4mM MgSO4, 0.6mM Ca(NO3)2,
5mM HEPES, pH 7.6) with 0.1% phenol red as injection dye. Full-length or
mutated DPM1 mRNA was cloned into pCS2þ for capped mRNA production.
mRNA was produced using the Ambion mMessage mMachine SP6 trascription kit.
Rescue injections were performed sequentially by injecting the MO and the mRNA
independently at the 1–2 cell stage in 60–100 embryos per condition. For each
clutch, at least four conditions were tested at the same time: un-injected wild types,
MO injection, rescue (MOþwild-type mRNA), mutant (MOþmutated mRNA).
Whenever sufficient embryos were available, an mRNA alone control was added or
multiple mutants were tested in parallel. Embryos were maintained at 28.5 C
and staged at hours (h) and days (d) post fertilization. For imaging and analysis
2–3 d.p.f. embryos were anaesthetized using 0.4% Tricaine stock and imaged on a
Leica M165 stereomicroscope. For knockdown quantification, mRNA was
extracted from control and experimental embryos using Promega ReliaPrep RNA
miniprep system and reverse transcribed using Bio-Rad iScript cDNA Synthesis kit.
qPCR was performed using Bio-Rad SsoFast EvaGreen Supermix on a Bio-Rad
CFX384 platform in the GWU Biomarker Core. Expression was normalized to
ribosomal protein L8 (rpl8). Primer sequences are available in Supplementary
Table 2.
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